亨廷顿病中神经乱性恶性综合征
Antonio Funcis1, Beatrice Ravera1, Paola Zinzi1,2
1Institute of Neurology, Catholic University of the Sacred Heart, Rome, Italy.
European journal of neurology
|October 24, 2024
概括
神经乱性恶性综合征 (NMS) 很少在接受多巴胺受体阻断剂 (DRBA) 治疗的亨廷顿病 (HD) 患者中被诊断为罕见. 风险因素包括晚期疾病,刚性-性表型和多疗法,强调需要谨慎的药物管理.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 多巴胺受体阻断剂 (DRBA) 在亨廷顿病 (HD) 中被广泛使用.
- 神经瘤恶性综合征 (NMS) 是DRBAs的一种罕见但严重的不良反应.
- 疾病发病患者的NMS患病率和风险因素尚未得到充分确立.
研究的目的:
- 为了评估NMS在HD患者的大队伍中的患病率.
- 在这个人群中识别与NMS相关的风险因素.
主要方法:
- 一个HD患者的NMS病例描述启动了叙事文献审查.
- 来自Enroll-HD研究 (PDS5) 的数据分析了DRBAs和/或tetrabenazine (TBZ) 的NMS核心症状的HD患者.
- 研究了NMS的患病率和风险因素.
主要成果:
- 在Enroll-HD PDS5数据集中的11569名HD患者中,5108人接受了DRBA和/或TBZ治疗.
- 只有一个患者 (0.02%) 已被注册诊断为NMS.
结论:
- 在亨廷顿病患者中很少描述NMS,可能是由于诊断不足.
- 缺乏客观的诊断标准和非典型的NMS表现使诊断复杂化.
- 关键的危险因素包括疾病晚期,刚性-性表型,药物突然改变,多疗法和脱水.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
227
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
227
Parkinson's Disease: Overview
486
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
486
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Mania and Antimanic Drugs: Overview
136
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
136
Antipsychotic Drugs: Therapeutic Uses and Side Effects
122
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
122
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
483
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
483


